申请人:CHIESI FARMACEUTICI S.p.A.
公开号:US10189844B2
公开(公告)日:2019-01-29
Compounds of formula (I) defined herein are phosphoinositide 3-kinases (PI3K) inhibitors and are useful for the treatment of disorders associated with PI3K enzymes.
本文定义的式(I)化合物是
磷酸肌醇 3-激酶(
PI3K)
抑制剂,可用于治疗与
PI3K 酶相关的疾病。